Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis
Exosome
PKM2
DOI:
10.1084/jem.20190158
Publication Date:
2019-09-23T19:04:12Z
AUTHORS (7)
ABSTRACT
Prostate cancer (PCa) metastasizes selectively to bone through unknown mechanisms. In the current study, we identified exosome-mediated transfer of pyruvate kinase M2 (PKM2) from PCa cells into marrow stromal (BMSCs) as a novel mechanism which primary tumor-derived exosomes promote premetastatic niche formation. We found that PKM2 up-regulates BMSC CXCL12 production in HIF-1α-dependent fashion, subsequently enhances seeding and growth marrow. Furthermore, serum-derived patients with either or metastasis, opposed healthy men, reveal increased exosome expression is associated suggesting clinical relevance PCa. Targeting exosome-induced axis diminished metastasis. summary, educate create BMSCs subsequent up-regulation CXCL12. This indicates potential for biomarker suggests therapeutic targets
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (138)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....